Biotech

All Articles

ArsenalBio raises $325M, rotates off of past lead property

.Collection Biosciences is actually proceeding up. The cell therapy firm has actually added $325 mil...

Lilly- backed weight reduction biotech documents IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has submitted ...

Aelis' marijuana use medication flunks period 2b, driving Indivior to reconsider $100M possibility

.Aelis Farma's chances of securing an easy, beneficial selection on a $one hundred thousand choice s...

ProKidney stops stage 3 test certainly not needed for cell treatment confirmation

.ProKidney has stopped some of a set of period 3 tests for its own cell treatment for kidney disease...

Vaxcyte rises on 'spectacular' 31-valent PCV succeed versus Pfizer

.Vaxcyte revealed what professionals referred to as "stunning" period 1/2 data for its own 31-valent...

Recursion's brain illness test reveals little proof of efficacy

.Recursion has actually discovered with an early examination of its own tech-enabled approach to med...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Contact it a scenario of good chemical make up: Acepodia, a biotech based on Nobel Champion scienti...

Praxis epilepsy medicine lowers confiscations in stage 2 litigation

.Praxis Preciseness Medicines has actually racked up one more midphase gain in epilepsy this year, a...

Three execs resign as Dyne blog posts mixed information for DMD prospect

.After getting away a clinical grip a number of years back, Dyne Therapeutics has shown brand-new st...

Arrowhead fires off phase 3 records in rare metabolic health condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its own hand in advance of a possible showdown with Ionis, rele...